1. 2167 Microsatellite status predicts BRAF V600E and KRAS exon 2 mutations prognostic value in stage III colon cancers (CC) patients treated with adjuvant FOLFOX +/- cetuximab. A post-hoc analysis of the PETACC8 trial. (September 2015) Authors: Taieb, J.; Zaanan, A.; Malicot, K. Le; Julie, C.; Blons, H.; Mineur, L.; Tabernero, J.; Mini, E.; Folprecht, G.; Laethem, J.L. Van; Lepage, C.; Emile, J.F.; Laurent-Puig, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2349 Phase 1b/2 study results for masitinib plus irinotecan in second-line treatment of esophagogastric adenocarcinoma. (September 2015) Authors: Zaanan, A.; Bennouna, J.; Hiret, S.; Douillard, J.Y.; Bouche, O.; Tougeron, D.; Lecomte, T.; Ezenfis, J.; Lepere, C.; Mansfield, C.; Moussy, A.; Dubreuil, P.; Hermine, O.; Taieb, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 714PGemcitabine and platinum- based chemotherapy in first line treatment of hepatocholangiocarcinoma: An AGEO multicenter retrospective study. (18th September 2017) Authors: Salimon, M.; Prieux-Klotz, C.; Tougeron, D.; Lecomte, T.; Caulet, M.; Matysiak Budnik, T.; Hautefeuille, V.; Tiako-Meyo, M.; Zaanan, A.; Touchefeu, Y. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunotherapy in advanced gastric cancer, is it the future?. (January 2019) Authors: Coutzac, C.; Pernot, S.; Chaput, N.; Zaanan, A. Journal: Critical reviews in oncology/hematology Issue: Volume 133(2019) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials. (July 2018) Authors: Adenis, A.; Alessio, A.; Aouakli, A.; Azzedine, A.; Bedjaoui, A.; Bidault, A.; Blanchi, A.; Botton, A.; Cadier-Lagnes, A.; Fatisse, A.; Gagnaire, A.; Gilbert, A.; Gueye, A.; Hollebecque, A.; Lemaire, A.; Mahamat, A.; Marre, A.; Patenotte, A.; Rotenberg, A.; Roussel, A. Journal: European journal of cancer Issue: Volume 98(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study. Issue 8 (May 2015) Authors: Tougeron, D.; Sickersen, G.; Mouillet, G.; Zaanan, A.; Trouilloud, I.; Coriat, R.; Aparicio, T.; Des Guetz, G.; Lecaille, C.; Artru, P.; Cauchin, E.; Sefrioui, D.; Boussaha, T.; Ferru, A.; Matysiak-Budnik, T.; Silvain, C.; Karayan-Tapon, L.; Pagès, J.C.; Vernerey, D.; Bonnetain, F. Journal: European journal of cancer Issue: Volume 51:Issue 8(2015:May) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗